CARERATINGBSECARE Ratings LtdHighNeutral
Announced Wed, 13 May · 20:52 IST

Financial Results for quarter and financials year ended March 31, 2026

Pat Growth 25pctRelated Party TransactionsResults View source PDF

CARERATING · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.0%1-day move
₹1595.00
prior close
₹1700.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.9+2.2+0.8+1.3+13.0+8.4+10.7+8.0+7.6+6.6+0.6+3.4+3.9
Up moveDown movePending
AI summary

CARE Ratings reported strong FY2026 results with consolidated revenue from operations growing 17.6% to Rs 47,307 lakhs and net profit rising 24.7% to Rs 17,118 lakhs compared to FY2025. Standalone revenue grew 15.2% to Rs 38,772 lakhs with net profit at Rs 17,439 lakhs, up 17.8% year-on-year. The Board declared a final dividend of Rs 14 per share, taking total FY26 dividend to Rs 22 per share (including Rs 8 interim). Statutory auditors B S R & Co. LLP issued unmodified opinions on both standalone and consolidated results. The company also approved 55,000 stock options at Rs 1,590 exercise price and reappointed its auditors for another 5-year term. Negotiations for selling partial stake in CareEdge Global IFSC to SBI and NSE IFSC are still ongoing.

Likely market impact

The 24.7% PAT growth and clean audit opinions signal strong operational performance and financial health, which is positive for shareholders. The continued dividend and stock option grants indicate management confidence, though investors should monitor the pending stake sale transaction.